Related references
Note: Only part of the references are listed.Estrogen receptor mutations and splice variants determined in liquid biopsies from metastatic breast cancer patients
Nick Beije et al.
MOLECULAR ONCOLOGY (2018)
Exosomes as diagnostic biomarkers in cancer
Jung-Hee Kim et al.
MOLECULAR & CELLULAR TOXICOLOGY (2018)
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen et al.
SCIENCE (2018)
A serum microRNA signature predicts trastuzumab benefit in HER2-positive metastatic breast cancer patients
Huiping Li et al.
NATURE COMMUNICATIONS (2018)
Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer
Ben O'Leary et al.
NATURE COMMUNICATIONS (2018)
Plasma thymidine kinase-1 activity predicts outcome in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with endocrine therapy
Martina Bonechi et al.
Oncotarget (2018)
LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer
T. Boulding et al.
SCIENTIFIC REPORTS (2018)
Liquid biopsy prediction of axillary lymph node metastasis, cancer recurrence, and patient survival in breast cancer A meta-analysis
Ju-Han Lee et al.
MEDICINE (2018)
ESR1 Methylation: A Liquid Biopsy-Based Epigenetic Assay for the Follow-up of Patients with Metastatic Breast Cancer Receiving Endocrine Treatment
Sophia Mastoraki et al.
CLINICAL CANCER RESEARCH (2018)
Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast Cancer
Giovanna Rossi et al.
CLINICAL CANCER RESEARCH (2018)
Circulating Cell Free Tumor DNA Detection as a Routine Tool for Lung Cancer Patient Management
Julie A. Vendrell et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
There is still a role for cytology in the 'liquid biopsy' era. A lesson from a TKI-treated patient showing adenocarcinoma to squamous cell carcinoma transition during disease progression
Eduardo Clery et al.
JOURNAL OF CLINICAL PATHOLOGY (2017)
Urine circulating-tumor DNA (ctDNA) detection of acquired EGFR T790M mutation in non-small-cell lung cancer: An outcomes and total cost-of-care analysis
Jacob Sands et al.
LUNG CANCER (2017)
Concordance of Genomic Alterations by Next-Generation Sequencing in Tumor Tissue versus Circulating Tumor DNA in Breast Cancer
Young Kwang Chae et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Cell-Free DNA from Ascites and Pleural Effusions: Molecular Insights into Genomic Aberrations and Disease Biology
Hatim Husain et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Integrating liquid biopsies into the management of cancer
Giulia Siravegna et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Are Small Breast Cancers Good because They Are Small or Small because They Are Good?
Donald R. Lannin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Intratumoral Heterogeneity in Breast Cancer: A Comparison of Primary and Metastatic Breast Cancers
Yu-Jie Shi et al.
ONCOLOGIST (2017)
Lipids in exosomes: Current knowledge and the way forward
Tore Skotland et al.
PROGRESS IN LIPID RESEARCH (2017)
Direct detection of early-stage cancers using circulating tumor DNA
Jillian Phallen et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Molecular heterogeneity in breast cancer: State of the science and implications for patient care
Rachel E. Ellsworth et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2017)
Current approaches for avoiding the limitations of circulating tumor cells detection methods-implications for diagnosis and treatment of patients with solid tumors
Artur Kowalik et al.
TRANSLATIONAL RESEARCH (2017)
Precision Oncology: The Road Ahead
Daniela Senft et al.
TRENDS IN MOLECULAR MEDICINE (2017)
Cell-free DNA detected by liquid biopsy as a potential prognostic biomarker in early breast cancer
Roberta Maltoni et al.
ONCOTARGET (2017)
Treatment-Induced Mutagenesis and Selective Pressures Sculpt Cancer Evolution
Subramanian Venkatesan et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Post surgery circulating free tumor DNA is a predictive biomarker for relapse of lung cancer
Wenwei Hu et al.
CANCER MEDICINE (2017)
Rapid and Sensitive Detection of Breast Cancer Cells in Patient Blood with Nuclease-Activated Probe Technology
Sven Kruspe et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases
Giulia Siravegna et al.
ESMO OPEN (2017)
Circulating microRNAs in patients with hormone receptor-positive, metastatic breast cancer treated with dovitinib
Narayan Shivapurkar et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2017)
Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancer
J. H. Chung et al.
ANNALS OF ONCOLOGY (2017)
The potential of liquid biopsies for the early detection of cancer
Ellen Heitzer et al.
NPJ PRECISION ONCOLOGY (2017)
Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy
Yu-Hsiang Chen et al.
NPJ BREAST CANCER (2017)
An evaluation of copy number variation detection tools for cancer using whole exome sequencing data
Fatima Zare et al.
BMC BIOINFORMATICS (2017)
Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients
Joost H. van Ginkel et al.
BMC CANCER (2017)
Liquid biopsies come of age: towards implementation of circulating tumour DNA
Jonathan C. M. Wan et al.
NATURE REVIEWS CANCER (2017)
Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients
Peilu Wang et al.
CLINICAL CANCER RESEARCH (2016)
Challenges in circulating tumor cell detection by the CellSearch system
Kiki C. Andree et al.
MOLECULAR ONCOLOGY (2016)
Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin
Matthew W. Snyder et al.
CELL (2016)
Detection of TP53/PIK3CA Mutations in Cell-Free Plasma DNA From Metastatic Breast Cancer Patients Using Next Generation Sequencing
Chiaki Nakauchi et al.
CLINICAL BREAST CANCER (2016)
Circulating tumor cell clusters: What we know and what we expect (Review)
Yupeng Hong et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
The biology and function of exosomes in cancer
Raghu Kalluri
JOURNAL OF CLINICAL INVESTIGATION (2016)
A novel minimal residual disease model of neuroblastoma in mice
Jeremy R. Jackson et al.
JOURNAL OF PEDIATRIC SURGERY (2016)
HER2 expression identifies dynamic functional states within circulating breast cancer cells
Nicole Vincent Jordan et al.
NATURE (2016)
Exosome cancer diagnostic reaches market
Cormac Sheridan
NATURE BIOTECHNOLOGY (2016)
Inferring expressed genes by whole-genome sequencing of plasma DNA
Peter Ulz et al.
NATURE GENETICS (2016)
Identification of tissue-specific cell death using methylation patterns of circulating DNA
Roni Lehmann-Werman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes
Joanna Kowal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Cell-free DNA as a diagnostic marker for cancer: current insights
Samanta Salvi et al.
ONCOTARGETS AND THERAPY (2016)
Analysis of tumor template from multiple compartments in a blood sample provides complementary access to peripheral tumor biomarkers
William M. Strauss et al.
ONCOTARGET (2016)
Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer
Kyung-A Hyun et al.
ONCOTARGET (2016)
Differential selective pressure alters rate of drug resistance acquisition in heterogeneous tumor populations
Daphne Sun et al.
SCIENTIFIC REPORTS (2016)
Circulating Tumor DNA Detection in Early-Stage Non-Small Cell Lung Cancer Patients by Targeted Sequencing
Ke-Zhong Chen et al.
SCIENTIFIC REPORTS (2016)
Targeted Next-Generation Sequencing of Plasma DNA from Cancer Patients: Factors Influencing Consistency with Tumour DNA and Prospective Investigation of Its Utility for Diagnosis
Pamela J. Kaisaki et al.
PLOS ONE (2016)
Circulating tumor cells in breast cancer patients
B. Bystricky et al.
NEOPLASMA (2016)
Accurate prediction of response to endocrine therapy in breast cancer patients: current and future biomarkers
Cigdem Selli et al.
BREAST CANCER RESEARCH (2016)
Liquid biopsy based biomarkers in non-small cell lung cancer for diagnosis and treatment monitoring
David Perez-Callejo et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2016)
Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment
Xiao-xiao Sun et al.
ACTA PHARMACOLOGICA SINICA (2015)
Reducing amplification artifacts in high multiplex amplicon sequencing by using molecular barcodes
Quan Peng et al.
BMC GENOMICS (2015)
PIK3CA mutations in serum DNA are predictive of recurrence in primary breast cancer patients
Chiya Oshiro et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Retrospective analysis of metastatic behaviour of breast cancer subtypes
C. Dilara Savci-Heijink et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Detection of K-ras gene mutation by liquid biopsy in patients with pancreatic cancer
Hideaki Kinugasa et al.
CANCER (2015)
RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics
Myron G. Best et al.
CANCER CELL (2015)
Gene expression profiles of circulating tumor cells versus primary tumors in metastatic breast cancer
Wendy Onstenk et al.
CANCER LETTERS (2015)
Noninvasive Detection of Activating Estrogen Receptor 1 (ESR1) Mutations in Estrogen Receptor-Positive Metastatic Breast Cancer
David S. Guttery et al.
CLINICAL CHEMISTRY (2015)
Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease
Eleonor Olsson et al.
EMBO MOLECULAR MEDICINE (2015)
Emerging platforms using liquid biopsy to detect EGFR mutations in lung cancer
Chien-Chung Lin et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2015)
Circulating tumor DNA (ctDNA) in nonmetastatic colorectal cancer (CRC): Potential role as a screening tool
Jeanne Tie et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Do Circulating Tumor Cells, Exosomes, and Circulating Tumor Nucleic Acids Have Clinical Utility? A Report of the Association for Molecular Pathology
Bert Gold et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2015)
Metastasis-promoting role of extravasated platelet activation in tumor
Tomoharu Miyashita et al.
JOURNAL OF SURGICAL RESEARCH (2015)
Frequent expression of PD-L1 on circulating breast cancer cells
Martine Mazel et al.
MOLECULAR ONCOLOGY (2015)
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
Bruno Costa-Silva et al.
NATURE CELL BIOLOGY (2015)
Big Bang and context-driven collapse
Mark Robertson-Tessi et al.
NATURE GENETICS (2015)
Subclonal diversification of primary breast cancer revealed by multiregion sequencing
Lucy R. Yates et al.
NATURE MEDICINE (2015)
Clinical management of breast cancer heterogeneity
Dimitrios Zardavas et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Circulating tumor-derived DNA is shorter than somatic DNA in plasma
Florent Mouliere et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
Isaac Garcia-Murillas et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Predicting Radiotherapy Responses and Treatment outcomes Through Analysis of Circulating Tumor DNA
Aadel A. Chaudhuri et al.
SEMINARS IN RADIATION ONCOLOGY (2015)
Detection of Clonal and Subclonal Copy-Number Variants in Cell-Free DNA from Patients with Breast Cancer Using a Massively Multiplexed PCR Methodology
Eser Kirkizlar et al.
TRANSLATIONAL ONCOLOGY (2015)
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma
Leticia De Mattos-Arruda et al.
NATURE COMMUNICATIONS (2015)
Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer
Muhammed Murtaza et al.
NATURE COMMUNICATIONS (2015)
Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma
Elin S. Gray et al.
ONCOTARGET (2015)
Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing
Frederic Amant et al.
JAMA ONCOLOGY (2015)
Circulating microRNA Biomarkers as Liquid Biopsy for Cancer Patients: Pros and Cons of Current Assays
Shigeshi Ono et al.
JOURNAL OF CLINICAL MEDICINE (2015)
Differential Platelet Levels Affect Response to Taxane-Based Therapy in Ovarian Cancer
Justin Bottsford-Miller et al.
CLINICAL CANCER RESEARCH (2015)
Gene Expression Profiling of Circulating Tumor Cells in Breast Cancer
Emanuela Fina et al.
CLINICAL CHEMISTRY (2015)
Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients
Jordan Madic et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients
Marta Pestrin et al.
MOLECULAR ONCOLOGY (2015)
EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer
Helen Schneck et al.
PLOS ONE (2015)
Expression of truncated human epidermal growth factor receptor 2 on circulating tumor cells of breast cancer patients
Galatea Kallergi et al.
BREAST CANCER RESEARCH (2015)
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle
L. De Mattos-Arruda et al.
ANNALS OF ONCOLOGY (2014)
MicroRNA in prostate cancer: functional importance and potential as circulating biomarkers
Benjamin L. Jackson et al.
BMC CANCER (2014)
Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing
Stephen Q. Wong et al.
BMC MEDICAL GENOMICS (2014)
Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis
Dharanija Madhavan et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer
S. Muenst et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Correlation between cell free DNA levels and medical evaluation of disease progression in systemic lupus erythematosus patients
Suzan Tug et al.
CELLULAR IMMUNOLOGY (2014)
Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer
Julia A. Beaver et al.
CLINICAL CANCER RESEARCH (2014)
Liquid Biopsies: Genotyping Circulating Tumor DNA
Luis A. Diaz et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Prognostic and Predictive Biomarkers: Tools in Personalized Oncology
Ewelina Nalejska et al.
MOLECULAR DIAGNOSIS & THERAPY (2014)
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
Francois-Clement Bidard et al.
LANCET ONCOLOGY (2014)
Tumor signatures in the blood
Michael R. Speicher et al.
NATURE BIOTECHNOLOGY (2014)
Molecular analysis of circulating tumour cells-biology and biomarkers
Matthew G. Krebs et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Exosomal HIF1α supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes
M. Aga et al.
ONCOGENE (2014)
Circulating tumor cells: Advances in isolation and analysis, and challenges for clinical applications
Ramdane Harouaka et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA
Daniel A. Haber et al.
CANCER DISCOVERY (2014)
Molecular and Cellular Heterogeneity in Breast Cancer Challenges for Personalized Medicine
Ashley G. Rivenbark et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Microfluidic flow fractionation device for label-free isolation of circulating tumor cells (CTCs) from breast cancer patients
Kyung-A Hyun et al.
BIOSENSORS & BIOELECTRONICS (2013)
EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2+, basal-like, and HER2 intrinsic subtypes of breast cancer
S. D. Soysal et al.
BRITISH JOURNAL OF CANCER (2013)
Circulating cell free DNA: Preanalytical considerations
Safia El Messaoudi et al.
CLINICA CHIMICA ACTA (2013)
Heterogeneity of Epidermal Growth Factor Receptor Status and Mutations of KRAS/PIK3CA in Circulating Tumor Cells of Patients with Colorectal Cancer
Christin Gasch et al.
CLINICAL CHEMISTRY (2013)
Cancer Genome Scanning in Plasma: Detection of Tumor-Associated Copy Number Aberrations, Single-Nucleotide Variants, and Tumoral Heterogeneity by Massively Parallel Sequencing
K. C. Allen Chan et al.
CLINICAL CHEMISTRY (2013)
Multiplex Picodroplet Digital PCR to Detect KRAS Mutations in Circulating DNA from the Plasma of Colorectal Cancer Patients
Valerie Taly et al.
CLINICAL CHEMISTRY (2013)
Treatment of Estrogen Receptor-Positive Breast Cancer
F. Lumachi et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
Irene Baccelli et al.
NATURE BIOTECHNOLOGY (2013)
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Sarah-Jane Dawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Single molecule quantitation and sequencing of rare translocations using microfluidic nested digital PCR
Joe Shuga et al.
NUCLEIC ACIDS RESEARCH (2013)
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Min Yu et al.
SCIENCE (2013)
Circulating tumor cells versus tumor-derived cell-free DNA: rivals or partners in cancer care in the era of single-cell analysis?
Evelyn Kidess et al.
GENOME MEDICINE (2013)
Tamoxifen Resistance in Breast Cancer
Minsun Chang
BIOMOLECULES & THERAPEUTICS (2012)
Platelets and platelet-like particles mediate intercellular RNA transfer
Antonina Risitano et al.
BLOOD (2012)
Circulating cell-free DNA: A promising marker of regional lymphonode metastasis in breast cancer patients
M. Agostini et al.
CANCER BIOMARKERS (2012)
Molecular biology in breast cancer: Intrinsic subtypes and signaling pathways
Pilar Eroles et al.
CANCER TREATMENT REVIEWS (2012)
EMT and Dissemination Precede Pancreatic Tumor Formation
Andrew D. Rhim et al.
CELL (2012)
The importance of examining the proportion of circulating DNA originating from tumor, microenvironment and normal cells in colorectal cancer patients
Florent Mouliere et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Genomic analysis of circulating cell-free DNA infers breast cancer dormancy
Jacqueline A. Shaw et al.
GENOME RESEARCH (2012)
Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy
Yi Lee et al.
HUMAN MOLECULAR GENETICS (2012)
Get on the exosome bus with ALIX
James H. Hurley et al.
NATURE CELL BIOLOGY (2012)
Cancer Progression Mediated by Horizontal Gene Transfer in an In Vivo Model
Catalina Trejo-Becerril et al.
PLOS ONE (2012)
Detection of ultra-rare mutations by next-generation sequencing
Michael W. Schmitt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
Tim Forshew et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Circulating Cell-Free DNA An Up-Coming Molecular Marker in Exercise Physiology
Sarah Breitbach et al.
SPORTS MEDICINE (2012)
Exosomes in Cancer Microenvironment and Beyond: have we Overlooked these Extracellular Messengers?
Ruowen Ge et al.
CANCER MICROENVIRONMENT (2012)
Blood platelets contain tumor-derived RNA biomarkers
R. Jonas A. Nilsson et al.
BLOOD (2011)
Accumulation of mutations over the entire mitochondrial genome of breast cancer cells obtained by tissue microdissection
Liane Fendt et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Circulating Cell-Free DNA in Plasma of Never Smokers with Advanced Lung Adenocarcinoma Receiving Gefitinib or Standard Chemotherapy as First-Line Therapy
Young Joo Lee et al.
CLINICAL CANCER RESEARCH (2011)
Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients
Bahriye Aktas et al.
GYNECOLOGIC ONCOLOGY (2011)
Breast Cancer 2 Gene expression profiling in breast cancer: classification, prognostication, and prediction
Jorge S. Reis-Filho et al.
LANCET (2011)
Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID
Cassandra B. Jabara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Cell-free nucleic acids as biomarkers in cancer patients
Heidi Schwarzenbach et al.
NATURE REVIEWS CANCER (2011)
Minimal residual disease and circulating tumor cells in breast cancer
Michail Ignatiadis et al.
BREAST CANCER RESEARCH (2011)
Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer
Ruth E. Board et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Portable Filter-Based Microdevice for Detection and Characterization of Circulating Tumor Cells
Henry K. Lin et al.
CLINICAL CANCER RESEARCH (2010)
Nucleosome Positioning, Nucleosome Spacing and the Nucleosome Code
David J. Clark
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2010)
Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing
Rebecca J. Leary et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus
Y. M. Dennis Lo et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients withMetastaticBreast Colorectal and Prostate Cancer
M. Craig Miller et al.
JOURNAL OF ONCOLOGY (2010)
Tumor Self-Seeding by Circulating Cancer Cells
Mi-Young Kim et al.
CELL (2009)
Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer
Theo deVos et al.
CLINICAL CHEMISTRY (2009)
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Sohrab P. Shah et al.
NATURE (2009)
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
Bahriye Aktas et al.
BREAST CANCER RESEARCH (2009)
Circulating DNA in the blood of gastric cancer patients
Elena V. Kolesnikova et al.
CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM V (2008)
Isolation and extraction of circulating tumor DNA from patients with small cell lung cancer
Ruth E. Board et al.
CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM V (2008)
Effect of cell-free DNA of patients with cardiomyopathy and rDNA on the frequency of contraction of electrically paced neonatal rat ventricular myocytes in culture
N. Bulicheva et al.
CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM V (2008)
Minimal residual disease is an important predictive factor of outcome in children with relapsed 'high-risk' acute lymphoblastic leukemia
M. Paganin et al.
LEUKEMIA (2008)
Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma
Rossa W. K. Chiu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood
H. Christina Fan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Circulating tumor cells (CTC) detection: Clinical impact and future directions
Patrizia Paterlini-Brechot et al.
CANCER LETTERS (2007)
Recent trends in breast cancer incidence rates by age and tumor characteristics among U. S. women
Ahmedin Jemal et al.
BREAST CANCER RESEARCH (2007)
Apoptosis: A review of programmed cell death
Susan Elmore
TOXICOLOGIC PATHOLOGY (2007)
Discovery and validation of breast cancer subtypes
Amy V. Kapp et al.
BMC GENOMICS (2006)
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival
Daniel F. Hayes et al.
CLINICAL CANCER RESEARCH (2006)
Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing
Roman K. Thomas et al.
NATURE MEDICINE (2006)
Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer
Hideharu Kimura et al.
CLINICAL CANCER RESEARCH (2006)
Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: Direct quantitative PCR for ALU repeats
Naoyuyi Umetani et al.
CLINICAL CHEMISTRY (2006)
Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis
Jason J. Christiansen et al.
CANCER RESEARCH (2006)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
Massimo Cristofanilli
SEMINARS IN ONCOLOGY (2006)
Detection and quantification of mutations in the plasma of patients with colorectal tumors
F Diehl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The role of macrophages in the in vitro generation of extracellular DNA from apoptotic and necrotic cells
JJ Choi et al.
IMMUNOLOGY (2005)
Tumor-specific p53 sequences in blood and peritoneal fluid of women with epithelial ovarian cancer
EM Swisher et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy
WA Osta et al.
CANCER RESEARCH (2004)
Microsatellite analysis of serum DNA in patients with head and neck cancer
H Nawroz-Danish et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Epithelial-mesenchymal transitions:: Twist in development and metastasis
YB Kang et al.
CELL (2004)
Apoptosis of circulating tumor cells in prostate cancer patients
CJ Larson et al.
CYTOMETRY PART A (2004)
Gene expression profiles and molecular markers to predict recurrence of dukes' B colon cancer
YX Wang et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Chromosomal DNA fragmentation in apoptosis and necrosis induced by oxidative stress
Y Higuchi
BIOCHEMICAL PHARMACOLOGY (2003)
Cellular microparticles: what are they bad or good for?
JM Freyssinet
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Circulating nucleic acids in plasma or serum
P Anker et al.
CLINICA CHIMICA ACTA (2001)
Optimization of ferrofluids and protocols for the enrichment of breast tumor cells in blood
PA Liberti et al.
JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS (2001)
CA 15-3: a prognostic marker in breast cancer
MJ Duffy et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2000)
Share Paper
